Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
447
1.950
 Why?
Endometrial Neoplasms
5
2015
138
0.890
 Why?
Gynecology
5
2020
49
0.850
 Why?
Genital Neoplasms, Female
2
2020
41
0.800
 Why?
Gene Expression Regulation, Neoplastic
10
2019
828
0.780
 Why?
Cystadenocarcinoma, Serous
4
2021
71
0.750
 Why?
Infection Control
1
2020
49
0.700
 Why?
Ethics, Medical
1
2020
45
0.690
 Why?
Communication
1
2020
246
0.620
 Why?
Conflict of Interest
3
2016
25
0.620
 Why?
Uterus
1
2018
94
0.600
 Why?
Medical Oncology
3
2020
95
0.600
 Why?
Robotics
2
2014
43
0.580
 Why?
Pneumonia, Viral
1
2020
169
0.570
 Why?
Peptides
3
2015
223
0.570
 Why?
Coronavirus Infections
1
2020
178
0.560
 Why?
Receptors, Estrogen
5
2017
131
0.560
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.530
 Why?
Fallopian Tube Neoplasms
2
2013
14
0.530
 Why?
Antineoplastic Agents, Hormonal
1
2015
48
0.510
 Why?
Pandemics
1
2020
562
0.510
 Why?
Glycoproteins
1
2015
117
0.500
 Why?
Gynecologic Surgical Procedures
2
2014
30
0.500
 Why?
Neoplastic Stem Cells
1
2015
103
0.490
 Why?
Adenocarcinoma
2
2015
397
0.480
 Why?
Antigens, CD
1
2015
221
0.480
 Why?
Female
34
2023
26635
0.440
 Why?
Salpingectomy
1
2013
6
0.440
 Why?
Peritoneal Neoplasms
2
2011
59
0.440
 Why?
MicroRNAs
4
2021
355
0.430
 Why?
Pelvic Neoplasms
1
2013
14
0.430
 Why?
General Surgery
1
2014
106
0.430
 Why?
Estrogens
2
2012
228
0.420
 Why?
Clinical Trials as Topic
2
2007
466
0.400
 Why?
Medicare Part B
1
2011
4
0.400
 Why?
Professional Corporations
1
2011
1
0.400
 Why?
Marketing of Health Services
1
2011
7
0.390
 Why?
Reimbursement Mechanisms
1
2011
23
0.390
 Why?
Physicians
2
2016
230
0.390
 Why?
Social Responsibility
1
2011
26
0.390
 Why?
Receptors, Progesterone
4
2015
64
0.390
 Why?
Cell Line, Tumor
11
2016
1416
0.380
 Why?
Trust
1
2011
59
0.380
 Why?
Humans
42
2023
50208
0.370
 Why?
Carcinoma, Large Cell
1
2010
15
0.370
 Why?
Carcinoma, Neuroendocrine
1
2010
24
0.370
 Why?
Interprofessional Relations
1
2011
85
0.360
 Why?
Health Care Reform
1
2010
22
0.360
 Why?
Physician-Patient Relations
1
2011
141
0.350
 Why?
Breast Neoplasms
4
2012
1179
0.340
 Why?
Uterine Neoplasms
2
2019
60
0.310
 Why?
Transplantation, Heterologous
2
2012
75
0.310
 Why?
Uterine Cervical Neoplasms
1
2010
276
0.300
 Why?
Physician's Role
2
2011
47
0.290
 Why?
MAP Kinase Kinase 4
1
2007
29
0.290
 Why?
Genes, Tumor Suppressor
1
2007
73
0.280
 Why?
Advance Directives
1
2007
29
0.280
 Why?
Apoptosis
5
2016
1112
0.280
 Why?
Patient Dropouts
1
2007
53
0.280
 Why?
Gene Expression Regulation, Enzymologic
1
2007
180
0.260
 Why?
Receptors, Transforming Growth Factor beta
1
2005
25
0.250
 Why?
Claudin-4
2
2016
7
0.250
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
990
0.240
 Why?
Ovary
1
2004
115
0.240
 Why?
Hysterectomy
2
2014
88
0.230
 Why?
Epithelial Cells
1
2004
207
0.220
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
595
0.220
 Why?
Aged
11
2021
9405
0.210
 Why?
Neoplasm Staging
4
2021
738
0.210
 Why?
Middle Aged
12
2021
12206
0.210
 Why?
Gene Expression Profiling
3
2019
1037
0.200
 Why?
Cisplatin
2
2015
278
0.190
 Why?
Immunohistochemistry
6
2017
978
0.180
 Why?
Cell Movement
3
2016
249
0.180
 Why?
Standard of Care
1
2020
16
0.180
 Why?
Resource Allocation
1
2020
16
0.180
 Why?
Disclosure
2
2016
39
0.180
 Why?
Loss of Heterozygosity
2
2013
77
0.180
 Why?
Lymphatic Metastasis
2
2010
227
0.170
 Why?
Early Detection of Cancer
1
2021
167
0.170
 Why?
Leiomyosarcoma
1
2019
23
0.170
 Why?
Leiomyoma
1
2019
25
0.170
 Why?
Neoplasm Invasiveness
3
2015
266
0.170
 Why?
Xenograft Model Antitumor Assays
4
2012
212
0.160
 Why?
RNA-Binding Proteins
2
2019
123
0.160
 Why?
Informed Consent
3
2004
97
0.160
 Why?
Death
1
2018
21
0.160
 Why?
Living Donors
1
2018
23
0.160
 Why?
Critical Care
1
2020
213
0.160
 Why?
Neoplasms, Glandular and Epithelial
2
2015
42
0.150
 Why?
Palliative Care
1
2020
186
0.150
 Why?
Carcinosarcoma
1
2017
18
0.150
 Why?
Microfilament Proteins
1
2017
43
0.150
 Why?
Sequence Analysis, RNA
1
2017
91
0.140
 Why?
United States
4
2016
4874
0.140
 Why?
Adult
7
2021
13324
0.140
 Why?
Mice, Nude
3
2012
254
0.140
 Why?
Industry
1
2016
17
0.130
 Why?
Keratin-5
1
2015
2
0.130
 Why?
Carrier Proteins
1
2017
306
0.130
 Why?
Receptors, Androgen
1
2015
46
0.130
 Why?
Cell Count
1
2015
149
0.130
 Why?
Prognosis
4
2017
1954
0.130
 Why?
Cell Proliferation
4
2015
1013
0.130
 Why?
Neoplasm Seeding
1
2014
4
0.120
 Why?
Genetic Privacy
2
2004
3
0.120
 Why?
Alanine
1
2014
42
0.120
 Why?
Triazines
1
2014
24
0.120
 Why?
Endometrium
1
2014
41
0.120
 Why?
Genes, BRCA2
1
2013
12
0.110
 Why?
Genes, BRCA1
1
2013
19
0.110
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.110
 Why?
Mice
6
2016
5759
0.110
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
7
0.110
 Why?
Health Care Costs
2
2013
170
0.110
 Why?
DNA Methylation
3
2023
550
0.110
 Why?
Risk Reduction Behavior
1
2013
59
0.110
 Why?
Carcinoma, Lobular
1
2012
33
0.110
 Why?
Paclitaxel
1
2012
84
0.100
 Why?
DNA-Binding Proteins
2
2013
428
0.100
 Why?
Lymph Nodes
1
2014
263
0.100
 Why?
Antibodies, Neoplasm
1
2012
28
0.100
 Why?
Coercion
1
2011
6
0.100
 Why?
Judicial Role
1
2011
6
0.100
 Why?
Medicare Payment Advisory Commission
1
2011
2
0.100
 Why?
Personal Autonomy
1
2011
15
0.100
 Why?
Women
1
2011
30
0.100
 Why?
Prejudice
1
2011
40
0.100
 Why?
Politics
1
2011
27
0.100
 Why?
Homeodomain Proteins
1
2012
80
0.100
 Why?
Quality of Health Care
1
2013
187
0.100
 Why?
Violence
1
2011
61
0.100
 Why?
M Phase Cell Cycle Checkpoints
1
2011
4
0.100
 Why?
Taxoids
1
2011
37
0.090
 Why?
Selective Estrogen Receptor Modulators
1
2010
24
0.090
 Why?
RNA, Messenger
2
2012
1108
0.090
 Why?
Organ Specificity
1
2010
108
0.090
 Why?
Immunoenzyme Techniques
1
2010
145
0.090
 Why?
Obstetrics
1
2011
88
0.090
 Why?
Models, Statistical
1
2011
224
0.090
 Why?
Neoplasm Recurrence, Local
1
2014
613
0.090
 Why?
Cesarean Section
1
2011
187
0.090
 Why?
Alcohol Drinking
1
2011
226
0.090
 Why?
Societies, Medical
1
2010
177
0.080
 Why?
Blotting, Western
1
2010
601
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
411
0.080
 Why?
Transfection
2
2012
355
0.080
 Why?
Phosphorylation
2
2008
534
0.080
 Why?
Animals
6
2016
13246
0.080
 Why?
Aged, 80 and over
4
2021
3154
0.080
 Why?
Aging
1
2013
688
0.080
 Why?
Alleles
2
2006
251
0.080
 Why?
Case-Control Studies
2
2014
1126
0.070
 Why?
Chimera
1
2007
9
0.070
 Why?
Antineoplastic Agents
1
2015
1186
0.070
 Why?
CpG Islands
1
2007
107
0.070
 Why?
MAP Kinase Signaling System
1
2007
118
0.070
 Why?
Genomic Imprinting
1
2006
11
0.070
 Why?
Health Services Accessibility
1
2010
399
0.070
 Why?
Insulin-Like Growth Factor II
1
2006
19
0.070
 Why?
RNA, Untranslated
1
2006
14
0.070
 Why?
Base Sequence
1
2007
644
0.060
 Why?
Repetitive Sequences, Amino Acid
1
2005
1
0.060
 Why?
Molecular Sequence Data
1
2007
793
0.060
 Why?
Models, Biological
2
2008
723
0.060
 Why?
North Carolina
1
2005
52
0.060
 Why?
Databases, Nucleic Acid
1
2004
12
0.060
 Why?
Telomerase
1
2004
27
0.060
 Why?
Carcinoma
1
2006
139
0.060
 Why?
Promoter Regions, Genetic
1
2007
475
0.060
 Why?
Polymorphism, Genetic
1
2005
181
0.060
 Why?
RNA Interference
2
2016
179
0.060
 Why?
Tumor Burden
2
2016
131
0.060
 Why?
RNA, Small Interfering
2
2016
215
0.060
 Why?
Cell Survival
2
2016
602
0.060
 Why?
Genetic Counseling
1
2004
38
0.060
 Why?
Family Health
1
2004
80
0.060
 Why?
Genomics
1
2004
285
0.050
 Why?
Epigenesis, Genetic
1
2006
378
0.050
 Why?
Researcher-Subject Relations
1
2002
1
0.050
 Why?
Ethical Review
1
2002
2
0.050
 Why?
Contract Services
1
2002
14
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Biotechnology
1
2002
12
0.050
 Why?
Health Care Sector
1
2002
15
0.050
 Why?
Genetic Predisposition to Disease
1
2005
509
0.050
 Why?
Mice, SCID
2
2012
176
0.050
 Why?
Cell Line
1
2004
1021
0.050
 Why?
Drug Industry
1
2002
38
0.050
 Why?
Research Support as Topic
1
2002
46
0.050
 Why?
Research Subjects
1
2002
49
0.050
 Why?
Neoplasm Grading
1
2021
123
0.050
 Why?
Patient Selection
1
2002
253
0.040
 Why?
Cooperative Behavior
1
2002
227
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
14
0.040
 Why?
Cytoskeletal Proteins
1
2019
49
0.040
 Why?
Risk Assessment
1
2023
1262
0.040
 Why?
Microtubule-Associated Proteins
1
2019
67
0.040
 Why?
Biomedical Research
1
2002
236
0.040
 Why?
Cell Cycle Proteins
1
2019
166
0.040
 Why?
Sensitivity and Specificity
1
2019
863
0.040
 Why?
Cohort Studies
1
2021
1422
0.040
 Why?
Caspase 3
1
2016
97
0.030
 Why?
Retrospective Studies
2
2021
6134
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Diagnosis, Differential
1
2019
1043
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
48
0.030
 Why?
Prospective Studies
1
2021
2379
0.030
 Why?
Exosomes
1
2015
50
0.030
 Why?
HEK293 Cells
1
2015
224
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
11
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
179
0.030
 Why?
Peritoneal Cavity
1
2014
8
0.030
 Why?
Risk Factors
2
2014
3629
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
202
0.030
 Why?
Drug Resistance, Neoplasm
1
2015
314
0.030
 Why?
Disease-Free Survival
1
2014
454
0.030
 Why?
Germ-Line Mutation
1
2013
61
0.030
 Why?
MCF-7 Cells
1
2013
69
0.030
 Why?
Amino Acid Substitution
1
2013
82
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Karyotyping
1
2012
83
0.030
 Why?
Extracellular Matrix Proteins
1
2013
69
0.030
 Why?
Anoikis
1
2012
8
0.030
 Why?
Transduction, Genetic
1
2012
45
0.030
 Why?
Databases, Factual
1
2016
657
0.030
 Why?
Tubulin
1
2012
23
0.030
 Why?
Mice, Inbred NOD
1
2012
96
0.030
 Why?
Tamoxifen
1
2012
60
0.030
 Why?
Signal Transduction
2
2011
1622
0.030
 Why?
DNA Fingerprinting
1
2012
62
0.030
 Why?
Cell Adhesion
1
2012
158
0.030
 Why?
Antibody Specificity
1
2012
36
0.030
 Why?
Tumor Suppressor Protein p53
1
2013
203
0.030
 Why?
Perioperative Period
1
2011
22
0.020
 Why?
Amino Acid Sequence
1
2013
586
0.020
 Why?
Estradiol
1
2012
225
0.020
 Why?
Disease Models, Animal
1
2016
1458
0.020
 Why?
Microtubules
1
2011
45
0.020
 Why?
Cell Cycle Checkpoints
1
2011
32
0.020
 Why?
Gene Expression
1
2013
609
0.020
 Why?
Mitosis
1
2011
93
0.020
 Why?
Regression Analysis
1
2011
395
0.020
 Why?
HeLa Cells
1
2011
260
0.020
 Why?
Disease Progression
1
2012
831
0.020
 Why?
Cells, Cultured
1
2013
1581
0.020
 Why?
Severity of Illness Index
1
2011
951
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Progesterone
1
2008
57
0.020
 Why?
Mutation
1
2013
1294
0.020
 Why?
Protein Kinases
1
2008
71
0.020
 Why?
Cell Nucleus
1
2008
187
0.020
 Why?
Tumor Cells, Cultured
1
2008
468
0.020
 Why?
Transcriptional Activation
1
2006
121
0.020
 Why?
DNA, Neoplasm
1
2006
147
0.020
 Why?
Protein Structure, Tertiary
1
2006
253
0.020
 Why?
Binding Sites
1
2006
375
0.020
 Why?
Repressor Proteins
1
2006
153
0.020
 Why?
Pregnancy
1
2011
2604
0.010
 Why?
Truth Disclosure
1
2004
14
0.010
 Why?
Genetic Diseases, Inborn
1
2004
23
0.010
 Why?
Male
1
2011
25399
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (38) people
_